Abbott Denied Summary Judgment in Humira Injury Case



DOCUMENTS
  • Order


MEMPHIS, Tenn. — A Tennessee federal judge has denied Abbott Laboratories Inc.’s (NYSE: ABT) motion for summary judgment in a Humira failure-to-warn case, ruling that the plaintiffs provided sufficient evidence that the drug maker agreed to toll the state’s statute of limitations on product liability claims.

On Dec. 6, Judge William G. Young of the U.S. District Court for the Western District of Tennessee found that an email proffered by plaintiffs is consistent with their position that Abbott had previously waived the statute of limitations defense for a specific time frame in an informal tolling agreement.

According to the June …

FIRM NAMES
  • Baker Donelson Bearman Caldwell & Berkowitz
  • Kirkland & Ellis
  • Law Office of Eddie Schmidt
  • Perdue Kidd & Vickery





UPCOMING CONFERENCES




HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS